Incyte (INCY) Misses Q3 EPS by 14c; Boosts FY15 Jakafi Net Revenue Outlook
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $120.16 -0.3%
Financial Fact:
Total revenues: 269.47M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total revenues: 269.47M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q3 EPS of ($0.22), $0.14 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $187.7 million versus the consensus estimate of $179.3 million.
The Company has updated its full year 2015 financial guidance, as detailed below.
| Previous Guidance | Updated Guidance | |||
| Jakafi net product revenues | $560-$575 million | $580-$590 million | ||
| Contract revenue (including milestone revenues) | $58 million | $78 million | ||
| Research and development expenses | $475-$500 million, includes non-cash stock compensation expense of $40-$45 million | Unchanged | ||
| Selling, general and administrative expenses | $195-$210 million, includes non-cash compensation expense of $30-$35 million | $200-$210 million, includes non-cash compensation expense of $30-$35 million |
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
